These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3111543)

  • 21. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
    Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A protein activator of galactosylceramide beta-galactosidase.
    Wenger DA; Sattler M; Roth S
    Biochim Biophys Acta; 1982 Sep; 712(3):639-49. PubMed ID: 7126630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of human hepatic beta-galactosidase toward natural glycosphingolipid substrates.
    Tanaka H; Meisler M; Suzuki K
    Biochim Biophys Acta; 1975 Sep; 398(3):452-63. PubMed ID: 1174525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Globoid cell leukodystrophy (Krabbe's disease). Metabolic studies with cultured fibroblasts.
    Tanaka H; Suzuki K
    J Neurol Sci; 1978 Oct; 38(3):409-19. PubMed ID: 731265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosine is as potent an inducer of cell death as C6-ceramide in cultured fibroblasts and in MOCH-1 cells.
    Tohyama J; Matsuda J; Suzuki K
    Neurochem Res; 2001 Jun; 26(6):667-71. PubMed ID: 11519726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A microassay for acid beta-galactosidase activity toward asialofetuin.
    Mutoh T; Naoi M; Sobue I; Kiuchi K; Nagatsu T
    Clin Chim Acta; 1985 Nov; 152(3):307-14. PubMed ID: 2415273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic properties of beta-galactosidase in Morquio B disease.
    Czartoryska B; Gorska D; Abramowicz T
    Acta Anthropogenet; 1983; 7(4):301-7. PubMed ID: 6439230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human brain cerebroside beta-galactosidase: deficiency of transgalactosidic activity in Krabbe's disease.
    Carter TP; Beblowski DW; Savage MH; Kanfer JN
    J Neurochem; 1980 Jan; 34(1):189-96. PubMed ID: 6778958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galactosylceramide and galactosylsphingosine loading studies in cultured skin fibroblasts in human and murine globoid cell leukodystrophy.
    Ida H; Kusano K; Suzuki H; Tokoro T; Eto Y
    Biochem Biophys Res Commun; 1990 Jan; 166(2):1053-60. PubMed ID: 2302222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate specificities of the two genetically distinct human brain beta-galactosidases.
    Tanaka H; Suzuki K
    Brain Res; 1977 Feb; 122(2):325-35. PubMed ID: 13910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-D-galactosidase activities in juvenile GM1-gangliosidosis.
    Hultberg B; Sjöblad S
    Acta Neurol Scand; 1978 Oct; 58(4):221-9. PubMed ID: 31052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrolysis of galactose from glycolipids and glycoprotein by young rat brain beta-galactosidases immobilized to Sepharose 4B.
    Yeung KK; McKinney RA; Dain JA
    J Neurochem; 1980 Aug; 35(2):407-11. PubMed ID: 6161222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical pathology of krabbe's disease. IV. Studies of galactosylceramide and lactosylceramide BETA-galactosidases in brain, white blood cells and aminotic fluid cells.
    Svennerholm L; Häkansson G; Vanier MT
    Acta Paediatr Scand; 1975 Jul; 64(4):649-56. PubMed ID: 1155085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psychosine: a "toxin" produced in the brain--its mechanism of action].
    Igisu H
    J UOEH; 1989 Dec; 11(4):487-93. PubMed ID: 2558407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry.
    Whitfield PD; Sharp PC; Taylor R; Meikle P
    J Lipid Res; 2001 Dec; 42(12):2092-5. PubMed ID: 11734583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and biochemical heterogeneity of globoid cell leukodystrophy.
    Farrell DF; Swedberg K
    Ann Neurol; 1981 Oct; 10(4):364-8. PubMed ID: 7316489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of phospholipids on substrate specificity of beta-galactosidase purified from Aspergillus oryzae.
    Naoi M; Yagi K
    Arch Biochem Biophys; 1982 Apr; 215(1):157-62. PubMed ID: 6807206
    [No Abstract]   [Full Text] [Related]  

  • 39. Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency.
    Van Diggelen OP; Schram AW; Sinnott ML; Smith PJ; Robinson D; Galjaard H
    Biochem J; 1981 Oct; 200(1):143-51. PubMed ID: 6800355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Globoid cell leukodystrophy: deficiency of lactosyl ceramide beta-galactosidase.
    Wenger DA; Sattler M; Hiatt W
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):854-7. PubMed ID: 4522795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.